Nektar Therapeutics (NKTR) Dipped -6.88% or -2.79 To Price $37.75 On Friday


Nektar Therapeutics (NKTR) dipped -6.88% or -2.79 to $37.75. It is near 1.59 million shares traded, which is 99.28% compare to the average total volume 1.60 million. The market cap of NKTR is $6.53 billion. The year to date change is 11.59%. The 52 week price range is from $29.22 to $111.36. Price of NKTR have changed 1.22% during last week. It have changed -7.70% over last month, 3.98% over last 3 months, -37.84% over last 6 months and -55.23% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NKTR is 40.25. It is 6.62% above current price. The 200-day Moving Averages for NKTR is 50.72. It is 34.36% above current price. The 52-week High is 111.36. It is 194.99% from the current price. The 52-week Low is 29.22. It is -22.60% from current price.

There are some statistics of NKTR. It is has market cap $6.53 billion. The share outstanding is 173.09 million. The average volume is 1.60 million. The percent of top 15 Institution holding is 164.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NKTR is 79.57%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NKTR is 52.68%.


Tags:

Share this post